MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,730,411 | +28.5% | 118,051 | +5.2% | 0.00% | 0.0% |
Q2 2023 | $2,902,356 | +101.9% | 112,190 | +87.4% | 0.00% | – |
Q1 2023 | $1,437,765 | +12.5% | 59,857 | -8.6% | 0.00% | – |
Q4 2022 | $1,277,485 | +0.0% | 65,512 | +7.8% | 0.00% | – |
Q3 2022 | $1,277,000 | -10.9% | 60,775 | -17.5% | 0.00% | – |
Q2 2022 | $1,433,000 | +178.3% | 73,647 | +215.2% | 0.00% | – |
Q1 2022 | $515,000 | +33.8% | 23,368 | -3.4% | 0.00% | – |
Q4 2021 | $385,000 | -18.9% | 24,194 | +1.5% | 0.00% | – |
Q3 2021 | $475,000 | +17.3% | 23,844 | +1.8% | 0.00% | – |
Q2 2021 | $405,000 | -24.2% | 23,428 | -12.9% | 0.00% | – |
Q1 2021 | $534,000 | +11.0% | 26,907 | -2.4% | 0.00% | – |
Q4 2020 | $481,000 | +28.6% | 27,570 | +41.9% | 0.00% | – |
Q3 2020 | $374,000 | -3.9% | 19,428 | -2.9% | 0.00% | – |
Q2 2020 | $389,000 | +62.1% | 20,003 | +16.8% | 0.00% | – |
Q1 2020 | $240,000 | -14.9% | 17,128 | +48.8% | 0.00% | – |
Q4 2019 | $282,000 | – | 11,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 1,921,118 | $38,077,000 | 5.86% |
FRAZIER MANAGEMENT LLC | 3,566,912 | $70,696,000 | 5.67% |
Burrage Capital Management LLC | 205,866 | $4,080,000 | 3.31% |
Novo Holdings A/S | 2,445,147 | $48,463,000 | 2.00% |
NEA Management Company, LLC | 4,187,801 | $83,002,000 | 1.86% |
Sio Capital Management, LLC | 437,138 | $8,664,000 | 1.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $68,357,000 | 1.44% |
Rock Springs Capital Management LP | 1,502,800 | $29,785,000 | 0.65% |
Sofinnova Investments, Inc. | 476,401 | $9,442,000 | 0.57% |
Boxer Capital, LLC | 317,000 | $6,283,000 | 0.21% |